Group 1: Company Overview - Shanda Electric Power is an indirect holding company of Shandong University, primarily engaged in the research, manufacturing, sales, and service of smart grid monitoring and new energy-related products [1][5] - The company is recognized as a national-level specialized and innovative "little giant" enterprise and a gazelle enterprise in Shandong Province [1] - The main products include fault recording monitoring devices, transmission line fault monitoring devices, and time synchronization devices [1] Group 2: Financial Information - Shanda Electric Power's initial public offering (IPO) price was 14.66 CNY per share, with an institutional offering price of 15.06 CNY per share, resulting in a market capitalization of 2.388 billion CNY [2] - The company's earnings per share (EPS) is projected at a price-to-earnings (P/E) ratio of 19.57, compared to the industry average P/E ratio of 20.25 [2] - Revenue from the smart grid monitoring sector is expected to be 5.76 million CNY, accounting for 87.94% of total revenue, while the new energy sector is projected to contribute 0.79 million CNY, or 12.06% [6] Group 3: Fundraising and Investment Plans - Shanda Electric Power plans to allocate 1.35 billion CNY (27.00%) for smart grid fault analysis and intelligent distribution network equipment production projects [4] - The company intends to invest 1.80 billion CNY (36.00%) in a research and development center project [4] - Additional investments include 0.40 billion CNY (8.00%) for new energy vehicle smart charging pile production and 0.90 billion CNY (18.00%) for working capital [5] Group 4: Market Position and Client Relationships - Shanda Electric Power has established long-term stable partnerships with major clients such as State Grid and Southern Power Grid, enhancing its competitive edge in the smart grid monitoring and new energy sectors [5] - The company operates 17 liaison offices across major cities in China, covering 22 provinces, 5 autonomous regions, and 4 municipalities [5] Group 5: Risks and Challenges - The company has reported lower research and development (R&D) investment levels compared to industry peers, with R&D expenses of 31.43 million CNY, 37.58 million CNY, and 45.96 million CNY from 2022 to 2024, resulting in R&D expense ratios of 6.57%, 6.84%, and 6.98% respectively [6] - Shanda Electric Power is highly sensitive to revenue fluctuations from State Grid, with sensitivity coefficients of 1.53, 1.36, and 1.29 for the years 2022 to 2024 [6] Group 6: Company Overview (Jiyuan Group) - Jiyuan Group specializes in the research and industrialization of dietary nutritional supplements, providing nutritional raw materials and formulations [7] - The company has developed into a leading global supplier of HMB raw materials and high-quality glucosamine products [11] Group 7: Financial Information (Jiyuan Group) - Jiyuan Group's IPO price was 10.88 CNY per share, with an institutional offering price of 11.09 CNY per share, resulting in a market capitalization of 4.352 billion CNY [8] - The company has a projected P/E ratio of 25.51, with comparable companies showing higher dynamic P/E ratios [8] Group 8: Fundraising and Investment Plans (Jiyuan Group) - Jiyuan Group plans to invest 2.06 billion CNY (34.23%) in the construction of a nutritional health raw material production base [10] - Additional investments include 1.47 billion CNY (24.44%) for expanding the production line of nutritional health foods and 0.99 billion CNY (16.45%) for a technology innovation center [10] Group 9: Market Position and Client Relationships (Jiyuan Group) - The company has established partnerships with numerous global brands, including Abbott, Sanofi, and Nestlé, for the supply of HMB and other nutritional products [11] - Jiyuan Group's revenue from nutritional raw materials is projected to be 5.71 million CNY, 6.09 million CNY, and 6.47 million CNY from 2022 to 2024, maintaining a revenue contribution of over 60% [11]

Core Viewpoint - The company aims to enhance public health through the development and sale of dietary nutritional supplements, focusing on early detection and prevention of health risks, particularly through the use of nutrients like HMB [2][9]. Company Overview - The company, 技源集团, has over 20 years of experience in the dietary nutritional supplement industry and has established a global network for R&D, production, sales, and service, becoming the largest supplier of HMB raw materials worldwide [2][4]. - The company went public on July 23, with plans to use the IPO proceeds to expand production capacity and enhance R&D capabilities [2][8]. Product and Market Focus - HMB is identified as a crucial nutrient for maintaining muscle health, particularly beneficial for individuals over 35, aiding in muscle preservation and recovery [3][6]. - The company has developed a comprehensive product line that includes various forms of HMB and is collaborating with major firms like 蒙牛 to create specialized products [6][7]. Financial Performance - The company has shown strong financial growth, with projected revenues of 940 million, 890 million, and 1 billion yuan from 2022 to 2024, respectively, and net profits of 140 million, 160 million, and 170 million yuan [8]. - The global dietary supplement market is growing, with a consumption scale exceeding $150 billion in 2021, indicating a robust demand for nutritional products [8]. Strategic Development - The company has transitioned from a trading model to an integrated platform model, enhancing its capabilities across the entire supply chain from raw material production to finished product formulation [4][7]. - The company holds 147 domestic and international patents, including a patented HMB and Vitamin D3 combination that has shown superior effects in clinical trials [6][5]. Industry Context - As China faces an aging population, there is an increasing emphasis on health and wellness, positioning the company to contribute significantly to public health initiatives [9].

Company Overview - Company is a leading global supplier of HMB (beta-hydroxy-beta-methylbutyrate) raw materials, holding over 50% market share globally and serving as the core supplier for Abbott's HMB products [1][2] - Established in 2002, the company has developed a strong vertical integration from raw material production to finished product formulation, enhancing its competitive edge in the industry [1][2] - The management team, led by US national Zhou Jingshi, has extensive experience in the nutrition raw materials sector, having previously worked with renowned companies like Amway and Avon [1][2] Financial Performance - The company reported revenues of 947 million yuan, 892 million yuan, and 1.002 billion yuan for the years 2022, 2023, and 2024, with year-on-year growth rates of 18.19%, -5.84%, and 12.33% respectively [3] - Net profits for the same years were 142 million yuan, 160 million yuan, and 174 million yuan, with growth rates of 29.34%, 12.63%, and 9.02% respectively [3] - Preliminary forecasts indicate a revenue increase of 15.03% to 273.6 million yuan and a net profit increase of 8.56% to 192 million yuan for the first half of 2025 compared to the same period in 2024 [3] Market Position and Industry Trends - The global dietary supplement market is projected to exceed $187 billion in 2023, with a steady growth rate of 6% expected, reaching $223 billion by 2026 [3] - The HMB market is anticipated to grow at a compound annual growth rate (CAGR) of approximately 11.54%, reaching an estimated production of 3,571.69 tons by 2030 [3] - The glucosamine market, in which the company is a key player, is expected to maintain a stable growth rate of 4.2% from 2022 to 2027, with a market demand of around 20,000 tons in 2022 [3] IPO Details - The company plans to issue 50.01 million new shares, raising approximately 544 million yuan, with funds allocated for three projects and working capital [4] - The projects include a production base for health raw materials, an expansion of the nutrition health food production line, and a technology innovation center [4] Valuation and Market Sentiment - The company's IPO price is set at 10.88 yuan per share, which is considered low compared to the average dynamic price-to-earnings ratio of comparable companies at 36.54, suggesting a potential upside of 49.51% on the first trading day [6][7] - Recent trends indicate that new stocks in the A-share market have experienced an average first-day increase of 230.68%, with a median increase of 174.56% [6][7] - The favorable market sentiment and the company's strong fundamentals may contribute to a positive performance on its debut [5][6]

技源集团股份有限公 章程(草案 (经 2023 年年度股东大会审议通过) 二〇二四年六月 4-2-1 机械 A 技源集团股份有限公司章程 第一章 总 则 第一条 为维护公司、股东和债权人的合法权益,规范公司的组织和行为, 根据《中华人民共和国公司法》(以下简称"《公司法》")等有关法律、行政法 规和相关规范性文件的规定,结合公司的实际情况,制订本章程。 第二条 技源集团股份有限公司是依照《公司法》和其他有关法律法规的规 定成立的股份有限公司(以下简称"公司")。 公司由江阴技源药业有限公司以整体变更方式设立;在无锡市市场监督管理 局注册登记,取得统一社会信用代码为 91320281741344724C 的营业执照。 | 第一节 通知 . | | --- | | 第二节 公告 . | | 第十章 合并、分立、增资、减资、解散和清算 | | 第一节 合并、分立、增资和减资 | | 第二节 解散和清算 | | 第十一章 修改章程 .. | | .. 第十二章 附则 | | 第一章 总 则 | | --- | | 第二章 经营宗旨和范围 | | 第三章 股 份 ………………………………………………………………………… ...

股票简称：技源集团 股票代码：603262 技源集团股份有限公司 TSI Group Co., Ltd. （江苏省江阴临港经济开发区锦绣路 2 号） 首次公开发行股票主板上市公告书 保荐人（主承销商） （上海市中山南路 318 号东方国际金融广场 24 层） 二零二五年七月二十二日 1 特别提示 技源集团股份股份有限公司（以下简称"技源集团"、"发行人"、"公司" 或"本公司"）股票将于 2025 年 7 月 23 日在上海证券交易所主板上市。本公司 提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新股上市初期 切忌盲目跟风"炒新"，应当审慎决策、理性投资。 2 第一节 重要声明与提示 一、重要声明 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏，并依 法承担法律责任。 上海证券交易所、有关政府机关对本公司股票上市及有关事项的意见，均不 表明对本公司的任何保证。 本 公 司 提 醒 广 大 投 资 者 认 真 阅 读 查 阅 刊 载 于 上 海 证 券 交 易 所 网站 （http://www.sse.com.c ...

技源集团股份有限公司 首次公开发行股票主板上市公告书 提示性公告 保荐人（主承销商）：东方证券股份有限公司 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、 完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，技源集团股份有限公司（以下简称"技源集团" 或"公司"）发行的人民币普通股股票将于 2025 年 7 月 23 日在上海证券交易所 主板上市，上市公告书全文和首次公开发行股票的招股说明书全文披露于上海证 券交易所网站（www.sse.com.cn）和符合中国证监会规定条件网站（中证网，网 址 www.cs.com.cn；中国证券网，网址 www.cnstock.com；证券时报网，网址 www.stcn.com；证券日报网，网址 www.zqrb.cn；经济参考网,网址 www.jjckb.cn）， 并置备于技源集团、上海证券交易所、本次发行保荐人（主承销商）东方证券股 份有限公司的住所，供投资者查阅。 一、上市概况 1、股票简称：技源集团 （二）流通股数量较少的风险 本次发行股数 5,001.00 万股，上市初期，原始股股东的股份锁定期 ...